RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
RXDX
Delisted
RXDX was delisted on the 15th of June, 2023.
116 hedge funds and large institutions have $870M invested in Prometheus Biosciences, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 35 increasing their positions, 36 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
17% less capital invested
Capital invested by funds: $1.04B → $870M (-$175M)
90% less call options, than puts
Call options by funds: $1.36M | Put options by funds: $13.9M
Holders
116
Holding in Top 10
5
Calls
$1.36M
Puts
$13.9M
Top Buyers
| 1 | +$37.2M | |
| 2 | +$20.9M | |
| 3 | +$17.9M | |
| 4 |
RI
RTW Investments
New York
|
+$12.2M |
| 5 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$10.9M |
Top Sellers
| 1 | -$21.4M | |
| 2 | -$14.2M | |
| 3 | -$11.3M | |
| 4 |
BlackRock
New York
|
-$9.71M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$9.25M |